Search Within

Craig Steven Sauter

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (24)
  2. Journal Article (13)
Groups
  1. Bone Marrow Transplant (37)
  2. Center for Hematologic Malignancies (37)
  3. Department of Medicine (37)
  4. GSK Faculty (37)
  5. Hematologic Malignancies, Division of (37)
  6. Human Oncology and Pathogenesis Program (37)

More Groups

People
  1. Sergio Giralt (25)
  2. Miguel-Angel Perales (24)
  3. Doris Ponce (21)
  4. Parastoo Dahi (21)
  5. Juliet Barker (20)
  6. Esperanza Papadopoulos (19)

More People

Years
  1. 2022 (2)
  2. 2021 (2)
  3. 2020 (5)
  4. 2019 (3)
  5. 2018 (6)
  6. 2017 (6)

More Years

Publications
  1. Blood (15)
  2. Biology of Blood and Marrow Transplantation (10)
  3. Journal of Clinical Investigation (2)
  4. Transplantation and Cellular Therapy (2)
  5. Blood Advances (1)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Elsevier Inc. (12)
  3. American Society for Clinical Investigation (2)
  4. Nature Publishing Group (2)
  5. American Association for Cancer Research (1)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (37)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma
    Journal Article

    Thomas, A. A.; Abrey, L. E.; Terziev, R.; Raizer, J.; Martinez, N. L.; Forsyth, P.; Paleologos, N.; Matasar, M.; Sauter, C. S.; Moskowitz, C.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Ibrutinib unmasks critical role of bruton tyrosine kinase in primary CNS lymphoma
    Journal Article

    Grommes, C.; Pastore, A.; Palaskas, N.; Tang, S. S.; Campos, C.; Schartz, D.; Codega, P.; Nichol, D.; Clark, O.; Hsieh, W. Y.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Time from prognosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Batlevi, C.; Alperovich, A.; Bantilan, K. S.; Palomba, M.; Gerecitano, J. F.; Noy, A.; Hamlin, P.; Moskowitz, C. H.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Journal Article

    Vardhana, S. A.; Sauter, C. S.; Matasar, M. J.; Zelenetz, A. D.; Galasso, N.; Woo, K. M.; Zhang, Z.; Moskowitz, C. H.
    British Journal of Haematology (2017)

    Fulltext@MSK | Save
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a feasible strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) after myeloablative adult allogeneic hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D. J.; Dahi, P.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • High progression-free survival (PFS) in adult double unit cord blood (dCB) transplant recipients with high risk disease after a novel intermediate intensity conditioning regimen
    Meeting Abstract

    Kosuri, S.; Hilden, P.; Devlin, S. M.; Yoo, Y.; Lauer, E.; Peled, J. U.; Avecilla, S.; Castro-Malaspina, H.; Dahi, P.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Meeting Abstract

    Vardhana, S. A.; Moskowitz, C. H.; Sauter, C. S.; Matasar, M. J.; Galasso, N.; Woo, K. M.; Zhang, Z. G.
    Blood (2015)

    Fulltext@MSK | Save
  • Age-adjusted co-morbidity core - but not revised Disease Risk Index - is associated with progression-free survival after intermediate intensity double unit CBT in adults with hematologic malignancies
    Meeting Abstract

    Kosuri, S.; Hilden, P.; Devlin, S.; Yoo, Y.; Lauer, E.; Peled, J.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Castro-Malaspina, H.; more...
    Blood (2015)

    Fulltext@MSK | Save